---
title: "Jaguar Health Amends Manufacturing and Supply Agreement With Woodward to Support 2026 Transition"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290840030.md"
description: "Jaguar Health amended its Manufacturing and Supply Agreement with Woodward Specialty to clarify inventory title transfer and transition responsibilities. Napo will manage inventory until December 31, 2026, with Woodward covering related costs. This amendment ensures business continuity during operational and licensing transitions, leaving other original terms unchanged."
datetime: "2026-06-25T13:23:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290840030.md)
  - [en](https://longbridge.com/en/news/290840030.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290840030.md)
generator: "portal-rs"
---

# Jaguar Health Amends Manufacturing and Supply Agreement With Woodward to Support 2026 Transition

Jaguar Health entered into a First Amendment to its Manufacturing and Supply Agreement with Woodward Specialty to clarify inventory title transfer and transition responsibilities. Napo will manage product inventory until the earlier of specified conditions or December 31, 2026, with Woodward covering certain related costs and liabilities. The amendment is intended to ensure business continuity while Woodward completes operational and licensing transitions. All other terms of the original agreement remain unchanged.

**Agreement details:**

-   **Agreement type**: First Amendment to Manufacturing and Supply Agreement
-   **Counterparty**: Woodward Specialty
-   **Signed / Effective**: Jun 22 2026 / same
-   **Duration / Termination**: Through Dec 31 2026 transition period
-   **Reason**: Ensure continuity during operational and licensing transition

Original SEC Filing: Jaguar Health, Inc. \[ JAGX \] - 8-K - Jun. 25, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [JAGX.US](https://longbridge.com/en/quote/JAGX.US.md)
- [WWD.US](https://longbridge.com/en/quote/WWD.US.md)

## Related News & Research

- [Woodward enters USD 450 million senior unsecured notes financing deal, closes Sept. 30](https://longbridge.com/en/news/296644839.md)
- [Woodward Secures $450 Million Senior Notes Private Placement, Maturing 2029–2033](https://longbridge.com/en/news/296644910.md)
- [JAGX: Q2 2026 revenue fell 60% year-over-year as focus shifted to rare disease drug development](https://longbridge.com/en/news/296396312.md)
- [Corning sets Q3 2026 dividend at R$ 0.25 per unit](https://longbridge.com/en/news/296635714.md)
- [INVEST: Revenue and profit dropped sharply in H1 2026, with 2026 outlook remaining subdued](https://longbridge.com/en/news/296439091.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**